NCT00524329View on ClinicalTrials.gov

Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage

CompletedOBSERVATIONAL
Enrollment

1,220

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

October 31, 2007

Conditions
Heartburn
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY